Folate overproduction can serve as a mode of resistance against the folate antagonist methotrexate in Lactobacillus plantarum WCFS1. When compared with a wild-type control strain, an engineered high folate-producing strain was found to be insensitive to methotrexate. The growth rate and the viable count of the folateoverproducing L. plantarum strain were not significantly affected by the presence of methotrexate in the growth medium.
Introduction
Folate antagonists such as methotrexate are chemically produced compounds with a broad use in therapeutics and medicine. Methotrexate, for example, is used as medicine against malaria to prevent growth of the parasite Plasmodium falciparum (Jelinek et al., 2002) . Moreover, it has been demonstrated that methotrexate has specific activity against some types of cancer (Skacel et al., 2005) . On the enzyme level, methotrexate competes with dihydrofolate for the binding site of dihydrofolate reductase (DHFR, EC 1.5.1.3) (Fig. 1) , resulting in depleted cellular tetrahydrofolate pools. Tetrahydrofolate and its derivatives are essential for the synthesis of purines, thymidylate, some amino acids and formylation of tRNA Met (Harvey, 1973; Jansen et al., 1998; Ulrich et al., 2001) (Fig. 1) . In lactic acid bacteria, the susceptibility to folate antagonists varies; Lactococcus lactis is known to be insensitive to the folate antagonist trimethoprim (Leszczynska et al., 1995) , whereas Lactobacillus plantarum and Lactobacillus casei are sensitive to this compound (Danielsen et al., 2004) . Prolonged exposure of target cells to folate antagonists such as methotrexate and trimethoprim might result in resistance. In cancer cells, several mechanisms were described such as: reduction of the folylpolyglutamate synthetase activity, amplification of the gene coding for DHFR or a decrease in the binding affinity for methotrexate on the DHFR (Tamura et al., 1997) . However, to date, folate overproduction has not been considered or described as a mode of resistance against methotrexate. Recently, a folate-overproducing L. plantarum WCFS1 strain was constructed by metabolic engineering (Wegkamp, 2008) . In this paper, we describe the sensitivity of this folate-overproducing strain toward methotrexate. Moreover, it was determined whether selected natural methotrexate-resistant colonies of L. plantarum were able to produce increased folate levels when compared with wild-type levels.
Strains, cultivation conditions and analysis
Lactobacillus plantarum WCFS1 (wild type) and L. plantarum WCFS1 strains harboring pNZ7021 (control vector, Wegkamp et al., 2007) and pNZ7026 (folate gene cluster expression vector, Wegkamp, 2008) were grown at 37 1C on chemically defined media (CDM) as described previously (Teusink et al., 2005) . It is important to note that the folate gene cluster expression vector does not harbor the gene coding for DHFR (folA). For specific experiments, a modified CDM was used; this medium lacks folate-dependent metabolites (glycine, inosine, orotic acid, thymidine, guanine, adenine, uracil and xanthine) and/or p-aminobenzoic acid (pABA) (the concentrations used were identical to what is described in the reference). CDM plates were made as follows: twofold concentrated CDM was mixed with an equal volume of 1% dissolved agarose (Invitrogen, Paisley, UK). All experiments were performed without assuring anaerobic conditions. A concentration of 80 mg L À1 chloramphenicol was used for plasmid maintenance. Folate was quantified using a microbiological assay as described previously (Horne & Patterson, 1988; Sybesma et al., 2003) . Methotrexate was purchased from Sigma, Steinheim, Germany. Specific growth rates of cultures of L. plantarum were determined in batch cultures and in 96-well microtiter plates by turbidity measurements at 600 nm using the Spectra Max384 spectrophotometer (Molecular Devices Inc., Sunnyvale, CA).
Folate overproduction as a mechanism for methotrexate resistance
For testing the hypothesis that folate overproduction leads to methotrexate resistance, it is crucial that folate overproduction is achieved on a growth medium that lacks the folate-dependent metabolites (glycine, inosine, orotic acid, thymidine, guanine, adenine, uracil and xanthine). This is important because it was shown that the omission of folate- dependent metabolites from the growth medium leads to a higher susceptibility toward methotrexate (Webb & Nickerson, 1956; Harvey, 1973) . We have tested folate production on a medium with and without folate-dependent metabolites for the control strain and the folate-overproducing strain (Table 1 ). The overproducing strain displayed 21-fold elevated intracellular folate pools on the growth medium lacking the folate-dependent metabolites when compared with the control strain, showing that high folate production can be achieved on this medium. In the presence of folatedependent metabolites, c. 55-fold increased intracellular folate production level was determined. Next, it was determined whether folate overproduction leads to reduced susceptibility toward methotrexate. The growth rates of the control strain and the folate-overproducing strain were determined on CDM supplemented with and without the folate-dependent metabolites. Methotrexate was used in concentrations ranging from 0 to 2.5 mg L À1 . Cultivation on CDM without the folate-dependent metabolites on methotrexate resulted in large growth effects for the control strain (Table 2 ). In the absence of methotrexate, it was found that the control strain had a 23% higher growth rate than the folate-overproducing strain. However, at an methotrexate concentration of 0.31 mg L À1 , the growth of the control strain was found to be 30% lower, when compared with the folate-overproducing strain. At increasing methotrexate concentrations, the relative growth rate differences increased; 4 days after inoculation, the culture of the control strain was still unable to grow at an methotrexate concentration of 2.5 mg L À1 , whereas the growth rate of the folateoverproducing strain was only slightly affected at this concentration of methotrexate. These experiments support our hypothesis that folate overproduction can serve as a mode of resistance toward methotrexate. In the presence of the folate-dependent metabolites, the growth rate of both the control strain and the folate-overproducing strain was unaffected by increasing the doses of methotrexate. Still, growth of the folate-overproducing strain was c. 21% lower when compared with the control strain for the tested methotrexate concentrations. This growth rate reduction of the folate-overproducing strain was similar to what was reported previously for this strain (Wegkamp, 2008) . Nevertheless, these experiments demonstrate that the presence of folate-dependent metabolites neutralizes the antimicrobial effects (growth rate reduction) of methotrexate, an effect that seems to be independent of folate overproduction.
Spontaneous methotrexate-resistant mutants
As reported in the previous paragraph, growth of the wildtype control strain was completely blocked on CDM lacking the folate-dependent metabolites at an methotrexate concentration of 2.5 mg L À1 . However, incubation of the cultures for an additional day revealed visible growth, suggesting that spontaneous methotrexate-resistant mutants emerged. The frequency of methotrexate-resistant cells was determined for the L. plantarum wild type, control and folate-overproducing strain by CFU counts on CDM plates 2903 (91) 216 (29) 2258 (248) 438 (29) SDs are shown in parentheses, based on three samples. (lacking folate-dependent metabolites) supplemented with 2.5 mg L À1 methotrexate. Spontaneous resistant mutants derived from the wild-type and control strain cultures were isolated with a mutation frequency of about 3 Â 10 À5 , for both cultures. This is in contrast to the plated cells from the folate-overproducing culture; nearly all folate-overproducing cells were able to grow on the CDM plates supplemented with methotrexate, confirming our previous observation that folate overproduction leads to methotrexate resistance. Finally, it was tested whether high folate pools or other secondary properties of the folate overproducer were responsible for methotrexate resistance. In order to test this, the folate overproducer was precultured on CDM without pABA and folate-dependent metabolites for 4 24 generations. Lactobacillus plantarum WCFS1 was found to be unable to produce folate in the absence of pABA (Wegkamp, 2008) . Aliquots of (the folate-deprived) overnight cultures were serially diluted and transferred to the CDM plates (without folate-dependent metabolites) in the presence and absence of pABA and harboring methotrexate (2.5 mg L À1 ).
From the plate analysis, it was found that folate-overproducing cells could be quantitatively recovered on CDM plates with pABA, whereas, in the absence of pABA only 1 in every 4 Â 10 5 cells was able to grow on CDM plates with methotrexate, showing that resistance toward methotrexate is directly linked to the ability to produce high folate pools.
Folate production in naturally resistant isolates
We have found that in populations of L. plantarum, natural resistance toward methotrexate occurs at a relatively high frequency of 3 Â 10 À5 . We have analyzed 576 single-colony isolates of these resistant strains for the size of their folate pool. One of the analyzed colonies displayed a 70% elevated folate pool when compared with the wild-type strain, showing that natural folate-overproducing strains could be isolated by screening methotrexate-resistant colonies. In contrast, a large screening for folate production on c. 20 000 randomly mutagenized wild-type L. plantarum WCFS1 did not reveal a single strain that produced significantly elevated folate pools (data not shown). This shows that screening for methotrexate-resistant singlecolony isolates may facilitate the search for natural folateoverproducing strains.
In this study, we have demonstrated that folate overproduction can serve as a resistance mechanism against the folate antagonist methotrexate. At the enzyme level, it is expected that high folate pools can give the organism a growth advantage, specifically because high folate pools can compete more efficiently with methotrexate for binding on DHFR. This phenomenon is particularly important on media that lack the folate-dependent metabolites. Specifically on these minimal growth media, folate overproduction can be a powerful resistance mechanism against methotrexate. Folate is only produced by plants, some fungi and some bacteria (Green & Matthews, 1996; Cossins & Chen, 1997; Hanson & Gregory, 2002) . Therefore, organisms belonging to these taxonomic groups serve as a potential source to select natural folate overproducers.
